Met160Val polymorphism in the TRMPSS2 gene and risk of prostate cancer in a population-based case-control study

Prostate

Volumn 59, Issue 4, 2004, Pages 357-359

  Lubieniecka, Joanna M ^a   Cheteri, Mahesh Keitheri ^a   Stanford, Janet L ^a,b   Ostrander, Elaine A ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Gene; Mutation; Serine protease; Urologic cancer

Indexed keywords

GENE PRODUCT; MEMBRANE PROTEIN; METHIONINE; SERINE PROTEINASE; VALINE;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CANCER INVASION; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FAMILY HISTORY; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; TRANSMEMBRANE SERINE PROTEASE 2 GENE; UNITED STATES;

ADULT; CASE-CONTROL STUDIES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PEDIGREE; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; RISK FACTORS; SERINE ENDOPEPTIDASES;

EID: 2442698917     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.20005     Document Type: Article

References (7)

1. Rittenhouse HG, Finlay JA, Mikolajczyk SD, Partin AW. Human kallikrein 2 (hK2) and prostate-specific antigen (PSA): Two closely related, but distinct, kallikreins in the prostate. Crit Rev Clin Lab Sci 1998;35:275-368.
2. Webber MM, Waghray A, Bello D. Prostate-specific antigen, a serine protease, facilitates human prostate cancer cell invasion. Clin Cancer Res 1995;1:1089-1094.
3. Nelson PS, Gan L, Ferguson C, Moss P, Gelinas R, Hood L, Wang K. Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression. Proc Natl Acad Sci USA 1999;96:3114-3119.
4. Lin B, Ferguson C, White JT, Wang S, Vessella R, True LD, Hood L, Nelson PS. Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2. Cancer Res 1999;59:4180-4184.
5. Yun Kim S, Park D, Oh M, Sellamuthu S, Park WJ. Detection of site-specific proteolysis in secretory pathways. Biochem Biophys Res Commun 2002;296:419-424.
6. Stanford JL, Wicklund KG, McKnight B, Daling JR, Brawer MK. Vasectomy and risk of prostate cancer. Cancer Epidemiol Biomark Prev 1999;8:881-886.
7. Breslow NE, Day NE. Statistical methods in cancer research. The analysis of case-control studies. IARC Scientific Publ. No. 1. Lyon, France: IARC, 1980.